Search papers, labs, and topics across Lattice.
This study evaluates the reliability of frozen hematology foundation models (FMs) across varying clinical settings by auditing 15 encoders for accuracy robustness and calibration against four public single-cell acquisition domains. While in-domain performance is high (macro-F1 scores of 0.98-0.997), cross-dataset performance reveals a significant drop of 34-72%, with notable shifts in ranking among models, highlighting vulnerabilities in deployment. The introduction of Class-Balanced Re-standardization (CBR) shows promise in improving target-prior scenario means and calibration, underscoring the need for comprehensive benchmarking in hematology FMs.
Cross-domain performance of frozen hematology models can plummet by up to 72%, revealing critical vulnerabilities in clinical deployment.
Frozen hematology foundation-model (FM) embeddings reach near-saturated in-domain white-blood-cell (WBC) accuracy, but clinical deployment demands reliability across scanners, sites, stains and preparation pipelines. We audit 15 frozen encoders (hematology, pathology, and general vision) across four public single-cell acquisition domains along two axes: accuracy robustness and calibration. In-domain linear-probe macro-F1 is saturated (0.98-0.997), yet cross-dataset macro-F1 drops 34-72% and rankings re-order: DinoBloom-L, the in-domain best, falls to 10th of 15 on the most-shifted target (MLL23) at the benchmark's shared 224-px input, behind RedDino and several general and pathology encoders. Rank transfer is probe-dependent: 1-NN retrieval is more stable on average than a source-fitted linear head (median $\rho$ 0.65 vs 0.45), but neither probe universally predicts target robustness. Calibration also collapses: source-trained probes are nearly calibrated in-domain (expected calibration error, ECE, 0.004) but confidently wrong off-domain (ECE 0.35), and source-fitted temperature scaling transfers poorly. We further audit pretraining exposure and identify MLL23 as DinoBloom's internal cohort; because DinoBloom's only held-out dataset is also our source domain, this benchmark cannot isolate exposure from scanner-associated shift. Label-free adaptation and marginal-entropy-based model selection appear safe under balanced evaluation but fail under realistic WBC class-prior shift. Class-Balanced Re-standardization (CBR), a training-free pseudo-label-balanced feature normalization, improves all evaluated target-prior scenario means and partially improves calibration, although encoder-level exceptions and residual miscalibration remain. Hematology FM benchmarks must therefore jointly audit accuracy, calibration, exposure, and class-prior robustness.